4.6 Article

Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells

Journal

JOURNAL OF IMMUNOLOGY
Volume 180, Issue 8, Pages 5283-5290

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.180.8.5283

Keywords

-

Categories

Funding

  1. NIAID NIH HHS [AI064591, R01 AI064591] Funding Source: Medline
  2. NIA NIH HHS [R37 AG023717, AG17618, AG28586, R01 AG025256, AG23717, AG025256] Funding Source: Medline

Ask authors/readers for more resources

Elderly humans have compromised Immoral and cellular immune responses, which lead to reduced protection to infectious agents and to vaccines. Currently, available vaccines suboptimally protect the elderly population. The capacity to class switch the Ig H chain is critical to the effectiveness of Immoral immune responses in mice and humans. We have previously shown in mice that the E2A-encoded transcription factor E47, which regulates many B cell functions, is down-regulated in old splenic B cells. This leads to a reduction in the activation-induced cytidine deaminase (AID), which is known to induce class switch recombination and Ig somatic hypermutation. The old activated murine B cells also have less AID and less switched Abs. We have extended our study here to investigate whether aging also affects Ab production and E47 and AID expression in B cells isolated from the peripheral blood of human subjects (18-86 years). Our results obtained with activated CD19(+) B cells show that the expression of E47, AID, and Ig gamma l circle transcripts progressively decrease with age. We also show an age-related decline in the percentage of switch memory B cells (IgG(+)/IgA(+)), an increase in that of naive B cells (IgG(-)/IgA(-)/CD27(-)) for most individuals, and no decrease in that of IgM memory cells in peripheral blood, consistent with our data on the decrease seen in class switch recombination in vitro. Our results provide a possible molecular mechanism for a B cell intrinsic defect in the Immoral immune response with aging and suggest avenues for improvement of vaccine response in elderly humans.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available